Status:
COMPLETED
Development of Novel Therapies for NIDDM
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Texas Southwestern Medical Center
Conditions:
Metabolism
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The overarching goal of this program project grant is the development of technologies that lead to new methods for studying, detecting, and treating type 2 diabetes, and their integration with hypothe...
Detailed Description
The overarching goal of this program project grant is the development of technologies that lead to new methods for studying, detecting, and treating type 2 diabetes, and their integration with hypothe...
Eligibility Criteria
Inclusion
- Good general health (normal vital signs; no acute signs or symptoms of illness)
- Able to give informed consent
- Able to tolerate study procedures including insertion of an intravenous catheter and approximately 90 minutes in the MRI scanner
- Aim 3 phase subjects will have BMI of 28 to 35 and a sedentary lifestyle; may be pre-diabetic or have undiagnosed type 2 diabetes
Exclusion
- Known diagnosed disease, including known heart rhythm disturbance, cancer or risk of seizure disorder or other disorder that could create risk to the subject
- Pregnancy
- Subjects with implanted metal that would compromise safety in MR use
- Subjects not fluent in English will be excluded because the immediate ability to respond to instructions in the scanner is required
Key Trial Info
Start Date :
December 10 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 17 2017
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT01905722
Start Date
December 10 2013
End Date
May 17 2017
Last Update
May 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390